Director, Global Real-World Evidence (RWE) - Oncology

Alternative Resources Company

Director, Global Real-World Evidence (RWE) - Oncology

Director, Global Real-World Evidence (RWE) – Oncology
 
Responsible for providing leadership and execution of Global RWE oncology research plans. Focus on marketed and/or pipeline compounds. Interface with cross-functional teams including Global Medical, Global Development, Global Commercial and Regional Medical and Commercial to align RWE strategies and evidence generation plans with Medical, Development and Commercial plans. Develop scientific communication materials such as manuscripts, conference presentations and internal training materials. Collaborate with thought leaders to develop scientific RWD to inform decisions of healthcare providers, major clinical organizations, guideline and pathway developers, reimbursement authorities and regulatory agencies. Develop close working relationship with the alliance partner(s) to drive Global RWE strategies and plans.
 
Responsibilities
  • Formulate Global RWE strategies aligned with the business and external stakeholders’ data needs. Develop scientifically rigorous and compelling RWD (Real World Data) that inform appropriate use of oncology products to improve patient outcomes.
  • Align RWE data communication strategy with healthcare stakeholders’ data needs and business strategy. Support the company’s mission as a credible and forthright contributor to the medical science and patient outcomes.
  • Align Global RWE strategies, timelines and budgets with Global Medical Affairs, Global Development, Global Commercial (Global Marketing and Global Market Access) and Regional Medical and Commercial teams.
  • Monitor current methodological, clinical practice and professional guidelines, as they relate to real world evidence, for the appropriate and optimal conduct of research and evaluations. Research projects need to be well-thought out to be effective and generate data to support decision-making of providers, payers and regulators to optimize use of products and support better patient outcomes. Travel to national and international meetings and conferences to support the business needs.          
  • Establish close working relationship with the alliance partner(s) counterparts. Collaboratively develop RWE study designs and execution plans.
 
Qualifications
  • Master’s degree (doctoral degree preferred) in health services research, public health, epidemiology, medicine, pharmacy administration or related discipline
  • A minimum of 6-year experience in Outcomes Research/Epidemiological Research/related discipline (with at least 4 years in oncology) either within biopharmaceutical industry and/or consulting/healthcare organization.
  • Experience in designing, collecting and analyzing RWD using EMRs, patient charts and administrative claims datasets.
  • Demonstrated ability to work collaboratively and leading cross-functional teams.
  • Expertise in the design and execution of RWE studies, including writing of protocols and analytic plans.
  • Ability to development professional relationships with customers, key opinion leaders and peers.
  • Outstanding communications and persuasion skills with a broad variety of audiences. Demonstrated strategic and conceptual skills to develop innovative approaches for developing optimal study designs.
  • Knowledge of pharmaceutical development, commercialization and lifecycle management
  • Knowledge of regulatory and industry guidelines in the delivery of health care information and dissemination of RWD in different regions of the world
  • Background in epidemiology, statistics and public health
  • Experience with utilization of RWE studies with major health care stakeholders including, providers and payers.
  • Experience supporting both marketed and pipeline assets
  • Global experience (U.S. and non-U.S. markets).